Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 35 (2022): Issue 2 (August 2022)
Open Access
The recent guidelines for pharmacotherapy of Parkinson’s Disease
Tomasz Karabin
Tomasz Karabin
,
Grazyna Biala
Grazyna Biala
and
Marta Kruk-Slomka
Marta Kruk-Slomka
| Sep 02, 2022
Current Issues in Pharmacy and Medical Sciences
Volume 35 (2022): Issue 2 (August 2022)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Sep 02, 2022
Page range:
80 - 85
Received:
Mar 05, 2022
Accepted:
Jun 10, 2022
DOI:
https://doi.org/10.2478/cipms-2022-0015
Keywords
Parkinson’s Disease (PD)
,
pharmacotherapy of PD
,
Dopamine Agonists
,
Anticholinergic Drugs
,
future treatment of PD
© 2022 Tomasz Karabin et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.